Pharmacists Believe in MMJ and Want Policy Changes

By David Jenison on May 13, 2019

Most pharmacists believe in medical cannabis and are seeking formal training for correct administration, yet prohibitionists prefer to wedge a bureaucrat between you and your doctor. According to several studies, even the medical community thinks that's stupid.

A 2019 survey of the California Pharmacists Association found that “a majority of providers believe that marijuana has medical efficacy… yet most providers report that they neither have much information about medical marijuana nor do they know where to get such information.” Likewise, 58 percent of pharmacy students in a 2015 survey support the national legalization of medical cannabis, while another study found that nearly 90 percent of prescribing healthcare professionals want more formal cannabis training. Even across the pond in England, where prohibition is much more stringent, nearly 90 percent of Royal Pharmaceutical Society members think cannabis should be rescheduled for increased medical access and the majority support legalization.

Similar support can be found in other fields. For example, the Journal of Drugs in Dermatology published a survey last December in which 86 percent of dermatologists thought cannabinoids should be legal for medical treatment, and 94 percent supported research into the dermatologic uses of cannabinoids.

Researchers with the Department of Veterans Affairs, of all places, explained why pharmacists face so many hurdles in terms of information, guidelines, access and prescribing rights in a study titled “Navigating Blind in the Green Rush.” They wrote, “Research on cannabis is difficult to conduct as it is classified as a Schedule I drug with high potential for abuse and currently no accepted medical use in treatment. As a result, no standard dosing procedures exist and the lack of conclusive scientific evidence has left clinical providers without evidence-based guidelines about if, when, and how to guide clients on using cannabis safely.”

The VA researchers also offered a recommendation for policy change: “The removal of regulatory barriers would enable researchers to address key public health questions about the potential therapeutic and adverse effects of cannabis use. Additionally, funds for research, clinician education, and public health education initiatives are necessary to reduce risk around cannabis use in the United States.”

Prohibitionists, your dumbass days are numbered.

The Cannabis Study Giving Xanax Producers Anxiety

Anti-Cannabis Researcher Links Prohibition to Big Pharma Profits

Nick Georgiou Channels Colors and Codices in New Exhibit

American Hemp: A Game-Changing Cash Crop

Scientific Paper Catalogs Oldest Known Connections Between Humans and Psychoactive Plants

Hemp Seeds Were Just Sent into Space for the First Time

Genetic Mutations in the Endocannabinoid System Render Scottish Woman Free from Pain and Anxiety

CBD Products in High-End Hotels

Best Events Around the World for May 2019

Election Upset: Denver Decriminalizes Magic Mushrooms!

Changa, the Psychedelic Challenge to Pharmaceutical Pain Medication

Bridging the Gap: How the Church and Cannabis Can Help Communities

The No. 1 Argument for Cannabis Legalization

EMAN8: The Story of a Broke Kid Whose Music Dreams Came True

The Neuroscientist Healing People with Nutrition and Frog Venom